DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 91 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,198,813 | -29.3% | 1,646,195 | -31.2% | 0.00% | -33.3% |
| Q2 2023 | $28,566,725 | -6.4% | 2,392,523 | +4.8% | 0.01% | -14.3% |
| Q1 2023 | $30,528,203 | -19.8% | 2,283,336 | +29.1% | 0.01% | -22.2% |
| Q4 2022 | $38,049,556 | +10.1% | 1,768,102 | +2.5% | 0.01% | +12.5% |
| Q3 2022 | $34,555,000 | +1.9% | 1,725,142 | -8.9% | 0.01% | 0.0% |
| Q2 2022 | $33,912,000 | +10839.4% | 1,894,537 | +5969.9% | 0.01% | – |
| Q1 2022 | $310,000 | -25.1% | 31,212 | +27.2% | 0.00% | – |
| Q4 2021 | $414,000 | +56.8% | 24,546 | +111.7% | 0.00% | – |
| Q2 2021 | $264,000 | – | 11,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |